Partners News Teaming up to develop an effective cure for mycobacterium abscessus disease
7 July 2021

PureIMS, Radboudumc, and Sever Pharma Solutions are joining forces to develop an effective cure for mycobacterium abscessus disease. Researchers at Radboudumc have found very promising results for inhaled administration of tigecycline.

Learn more

Related news items

Radboudumc enhances Luchtbrug in collaboration with FindAir

17 August 2021

Luchtbrug is a platform for online asthma care for children and young people, which (partly) replaces outpatient visits.

read more

Radboudumc and SyncVR Medical looking to boost the use of virtual reality in healthcare

15 July 2021

Aiming to provide better care with the help of virtual reality applications, Radboudumc is going to collaborate intensively with startup SyncVR Medical. To this end, the two partners signed a two-year collaboration agreement.

read more

Radboudumc and Eindhoven University of Technology join forces in BIOTRIP Biotech incubator to deliver the vaccines and immunotherapies of the future.

1 July 2021

BIOTRIP is a unique platform aimed at developing, commercializing, and making available of vaccins and immunotherapies.

read more

Saving lives with a small pump inside the heart CardiacBooster

15 June 2021

Less damage to organs and a greater chance of survival after having a heart attack. That's what Radboudumc spin-off CardiacBooster is aiming to accomplish.

read more

First volunteers vaccinated with Radboudumc malaria vaccine

20 May 2021

Today a new vaccine against malaria, largely developed in Nijmegen, is being tested for the first time in volunteers at Radboudumc.

read more